Amyloid-β 42 (Aβ 42 ) accumulates within senileplaque, a pathological hall mark of Alzheimer’s disease (AD). Our previous reports showed that the monoclonal antibodies 37-11 and 77-3 react with conformational epitopes on the surface of the soluble aggregates of Aβ 42 and that sandwich ELISA using these two monoclonal antibodies yields high reactivity to detect soluble aggregates of Aβ 42 . Here, the reactivity of the sandwich ELISA was shown to increase in the presence of 50 μM Cu 2+ . However, the addition of Cu 2+ had only a small effect on the reactivity of a direct ELISA using antibody 37-11 or 77-3, suggesting that Cu 2+ has a small effect on the number of epitopes on the surface of the aggregates. Atomic force microscopy images showed that larger aggregates were formed in the presence of Cu 2+ , as shown in the other reports. Cu 2+ may gather the aggregates with distinct epitopes recognized by antibodies 37-11 and 77-3, leading to increased signal intensity of the sandwich ELISA.
Awasthi, M., Singh, S., Pandey, V.P. and Dwivedi, U.N. (2016) Alzheimer’s Disease: An Overview of Amyloid Beta Dependent Pathogenesis and Its Therapeutic Implications along with In Silico Approaches Emphasizing the Role of Natural Products. Journal of Neurological Sciences, 361, 256-271. http://dx.doi.org/10.1016/j.jns.2016.01.008
Hardy, J.A. and Higgins, G.A. (1992) Alzheimer’s Disease: The Amyloid Cascade Hypothesis. Science, 256, 184-185. http://dx.doi.org/10.1126/science.1566067
vanOijen, M., Hofman, A., Soares, H.D., Koudstaal, P.J. and Breteler, M.M. (2006) Plasma Abeta(1-40) and Abeta(1-42) and the Risk of Dementia: A Prospective Case-Cohort Study. Lancet Neurology, 5, 655-660. http://dx.doi.org/10.1016/S1474-4422(06)70501-4
Suzuki, N., Cheung, T.T., Cai, X.D., Odaka. A., Otvos, L. Jr., Eckman, C., Golde, T.E. and Younkin, S.G. (1994) An Increased Percentage of Long Amyloid Beta Protein Secreted by Familial Amyloid Beta Protein Precursor (Beta APP717) Mutants. Science, 264, 1336-1340. http://dx.doi.org/10.1126/science.8191290
Chimon, S., Shaibat, M.A., Jones, C.R., Calero, D.C., Aizezi, B. and Ishii, Y. (2007) Evidence of Fibril-Like β-Sheet Structures in a Neurotoxic Amyloid Intermediate of Alzheimer’s β-Amyloid. Nature Structural & Molecular Biology, 14, 1157-1164. http://dx.doi.org/10.1038/nsmb1345
O'Nuallain, B., Freir, D.B., Nicoll, A.J., Risse, E., Ferguson, N., Herron, C.E., Collinge, J. and Walsh, D.M. (2010) Amyloid Beta-Protein Dimers Rapidly Form Stable Synaptotoxicprotofibrils. The Journal of Neuroscience, 30, 14411-14419. http://dx.doi.org/10.1523/JNEUROSCI.3537-10.2010
Dickson, D.W. (1997) The Pathogenesis of Senile Plaques. Journal of Neuropathology & Experimental Neurology, 56, 1285-1290. http://dx.doi.org/10.1097/00005072-199704000-00001
Ochiishi, T., Itakura, A., Liu, L., Akatsu, H., Kohno, H., Nishimura, M. and Yoshimune, K. (2016) Immunohistochemical Detection of the Delayed Formation of Nonfibrillar Large Amyloid-β Aggregates. Genes Cells, 21, 200-211. http://dx.doi.org/10.1111/gtc.12332
Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L. and other 5 authors (1998) Diffusible, Nonfibrillar Ligands Derived from Abeta1-42 Are Potent Central Nervous System Neurotoxins. The Proceedings of the National Academy of Sciences of the United States of America, 95, 6448-6453. http://dx.doi.org/10.1073/pnas.95.11.6448
Barghorn, S., Nimmrich, V., Striebinger A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R.S., Harlan, J., et al. (2005) Globular Amyloid Beta-Peptide Oligomer —A Homogenous and Stable Neuropathological Protein in Alzheimer’s Disease. Journal of Neurochemistry, 95, 834-847. http://dx.doi.org/10.1111/j.1471-4159.2005.03407.x
Matsumura, S., Shinoda, K., Yamada, M., Yokojima, S., Inoue, M., Ohnishi, T., Shimada, T., Kikuchi, K., Masui, D., Hashimoto, S. and other 14 authors (2011) Two Distinct Amyloid Beta-Protein (Abeta) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses. Journal of Biological Chemistry, 286, 11555-11562. http://dx.doi.org/10.1074/jbc.M110.181313
Shimizu, T., Yoshimune, K., Komoriya, T., Akiyama, T., Ye, X. and Kohno, H. (2013) Monoclonal Antibodies against Large Oval Aggregates of Aβ1-42. Journal of Bioscience and Bioengineering 115, 216-220. http://dx.doi.org/10.1016/j.jbiosc.2012.09.007
Shimizu, T., Yoshimune, K., Komoriya, T., Akiyama, T., Ye, X. and Kohno, H. (2013) Combination of Specific Monoclonal Antibodies Allow Identification of Soluble Aggregates of Aβ1-42 by Sandwich ELISA. Advances in Bioscience and Biotechnology, 4, 63-66. http://dx.doi.org/10.4236/abb.2013.44A009
Branch, T., Girvan, P., Barahona, M. and Ying, L. (2015) Introduction of a Fluorescent Probe to Amyloid-β to Reveal Kinetic Insights into Its Interactions with Copper(II). Angewandte Chemie International Edition, 54, 1227-1230. http://dx.doi.org/10.1002/anie.201408810
Ryan, T.M., Kirby, N., Mertens, H.D., Roberts, B., Barnham, K.J., Cappai, R., Pham, Cle L., Masters, C.L. and Curtain, C.C. (2015) Small Angle X-Ray Scattering Analysis of Cu(2+)-Induced Oligomers of the Alzheimer’s Amyloid β Peptide. Metallomics, 7, 536-543. http://dx.doi.org/10.1039/C4MT00323C
Jiang, D., Rauda, I., Han, S., Chen, S. and Zhou, F. (2012) Aggregation Pathways of the Amyloid β(1-42) Peptide Depend on Its Colloidal Stability and Ordered β-Sheet Stacking. Langmuir, 28, 12711-12721. http://dx.doi.org/10.1021/la3021436
Shimanouchi, T., Onishi, R., Kitaura, N., Umakoshi, H. and Kuboi, R. (2011) Copper-Mediated Growth of Amyloid β Fibrils in the Presence of Oxidized and Negatively Charged Liposomes. Journal of Bioscience and Bioengineering, 112, 611-615. http://dx.doi.org/10.1016/j.jbiosc.2011.08.015
Tougu, V., Karafin, A., Zovo, K., Chung, R.S., Howells, C., West, A.K. and Palumaa, P. (2009) Zn(II)- and Cu(II)-Induced Non-Fibrillar Aggregates of Amyloid-Beta (1-42) Peptide Are Transformed to Amyloid Fibrils, Both Spontaneously and Under the Influence of Metal Chelators. Journal of Neurochemistry, 110, 1784-1795. http://dx.doi.org/10.1111/j.1471-4159.2009.06269.x
Blennow, K., Mattsson, N., Scholl, M., Hansson, O. and Zetterberg, H. (2015) Amyloid Biomarkers in Alzheimer’s Disease. Trends in Pharmacological Sciences, 36, 297-309. http://dx.doi.org/10.1016/j.tips.2015.03.002
Holtta, M., Hansson, O., Andreasson, U., Hertze, J., Minthon, L., Nagga, K., Andreasen, N., Zetterberg, H. and Blennow, K. (2013) Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease. PLoS One, 8, e66381. http://dx.doi.org/10.1371/journal.pone.0066381
Shimizu, T., Yoshimune, K., Komoriya, T., Ogawa, M., Akiyama, T., Ye, X. and Kohno, H. (2015) Classification of Monoclonal Antibodies to Measure the Progress of Aβ1-42 Aggregation. Global Journal for Research Analysis, 4, 117-119.
Twomey, P.J., Viljoen, A., House, I.M., Reynolds, T.M. and Wierzbicki, A.S. (2005) Relationship between Serum Copper, Ceruloplasmin, and Non-Ceruloplasmin-Bound Copper in Routine Clinical Practice. Clinical Chemistry, 51, 1558-1559. http://dx.doi.org/10.1373/clinchem.2005.052688